Description
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Triamcinolone acetonide | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Triamcinolone acetonide | HTML | Open resource |